Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
View Patent ↗A method for treating Chronic Obstructive Pulmonary Disease (COPD) or chronic bronchitis to alleviate the discomforts of breathing by using non-thermal electroporation energy to ablate diseased portions of the lung including the bronchus, airways and alveoli which, in effect, opens the restrictive diseased portions thereby maximizing the overall surface area thereof causing improved airflow and uninhibited breathing.
1. A method of treating lung tissue comprising:
obtaining access to the lung, wherein the lung comprises a target region and wherein the access comprises advancing at least one energy delivery device through the trachea, the at least one energy delivery device comprising an expandable member configured to expand at least one electrode;
positioning the at least one energy delivery device within an airway of the target region, wherein the energy delivery device is coupled to an energy source;
expanding the expandable member to partially expand the airway, and
applying electrical pulses via the at least one electrode sufficient to irreversibly electroborate the target region.
2. The method of claim 1 , wherein the step of positioning the at least one energy delivery device comprises: positioning the at least one energy delivery device within a diseased region of an inner wail of a bronchus of the lung.
3. The method of claim 2 , wherein the step of inserting the at least one energy delivery device comprises; advancing the at least one energy delivery device through a patient's trachea prior to inserting the at least one energy delivery device within a diseased region of the bronchus.
4. The method of claim 3 , wherein the step of applying the electrical pulses comprises applying the electrical pulses using a balloon electrode.
5. The method of claim 4 , further comprising placing the balloon electrode in contact with the inner wall of the bronchus and ablating the target region to substantially increase a diameter of the bronchus.
6. The method of claim 2 , wherein the step of positioning further comprises positioning the at least one energy delivery device endo-bronchially or exo-bronchially.
7. The method of claim 2 , wherein the step of accessing further comprises positioning the at least one energy delivery device using one or more of a surgical, laparoscopic, percutaneous, and endotracheal method.
8. The method of claim 2 , wherein the step of irreversible electroporation further comprises ablating a diseased region, wherein the diseased region is caused by bronchitis.
9. The method of claim 1 , wherein the step of ablating further comprises ablating at an energy field strength in the range of between about 100V/cm to greater than about 10,000V/cm.
10. The method of claim 1 , wherein the step of positioning the at least one energy delivery device comprises: inserting the at least one energy delivery device within a diseased region of an alveolus of the lung.
11. The method of claim 10 , wherein the step of inserting the at least one energy delivery device comprises: obtaining access percutaneously prior to inserting the at least one energy delivery device within the target region of the alveolus.
12. The method of claim 11 , wherein the step of applying the electrical pulses comprises applying the electrical pulses using a probe comprising deployable tines.
13. The method of claim 12 , further comprising applying the electrical pulses directly into tissue adjacent the alveoli and ablating the target region to substantially decrease lung volume and increase lung function.
14. The method of claim 10 , wherein the step of positioning further comprises positioning the at least one energy delivery device endo-bronchially or exo-bronchiaily.
15. The method of claim 14 , wherein the method further comprises providing a catheter and inserting the flexible IRE device through the catheter to the target region.
16. The method of claim 15 , wherein the method further comprises retracting the flexible IRE device into the catheter and redeploying the catheter into a bronchus of the lung.
17. The method of claim 1 , wherein the step of irreversible electroporation further comprises applying the electrical pulses in a pulse train of between about 1 and about 15 electrical pulses.
18. The method of claim 10 , wherein the step of irreversible electroporation further comprises ablating a diseased region, wherein the diseased region is caused by emphysema.
19. The method of claim 1 , wherein the step of ablating further comprises delivering electrical pulses between 20 and 100 microseconds in length.
20. The method of claim 1 . wherein the step of applying the electrical pulses comprises applying the electrical pulses using a flexible IRE device.